WESTLAKE, OH – Nordson Corporation announced sales of $610 million in the first quarter of its fiscal year, a small increase from last year's first quarter sales of $609 million.

The company's Industrial Precision Solutions segment saw 1% year-to-year growth to reach $312 million, and its Medical and Fluid Solutions segment's sales decreased 3% to total $154 million in the first quarter. The Advanced Technology Solutions segment saw sales of $145 million, an increase of 14%.

Nordson also updated its full-year revenue growth guidance to 0% to 3% over the record growth it saw in 2022.

"First quarter results were in line with our expectations," said Sundaram Nagarajan, president and chief executive officer. "Our team delivered sales growth comparable to a record fiscal first quarter 2022 despite unfavorable currency headwinds, the timing of the Chinese New Year, and the unexpected negative impact from the spread of COVID-19 in China. Growth was driven by the benefits of our CyberOptics acquisition, as well as solid demand in industrial and medical interventional solutions product lines. The diversity of our geographies and product lines in Europe and Americas, as well as our steadfast dedication to advancing the NBS Next growth framework and responding to the needs of our customers, continues to deliver high quality business performance in dynamic market conditions."

• Prev
• Next